Glenn Bubley, MD
Associate Professor
Medical Oncology
Contact Information
| Office: | CL-449 |
| Phone: | 617-735-2062 |
| Fax: | |
| Email: | gbubley@bidmc.harvard.edu |
| Address: | 330 Brookline Ave; CL-449
Boston, MA 02215 |
Areas of Interest
| 1 Cancer |
Major Research Theme
| We have a multi-discipline translational group focused on prostate cancer. Dr. Balk is responsible for the basic research portion of our group activities and I am responsible for the clinical research activities. However, Dr. Balk has clinical interests and I have basic research interests. I am approximately 70% clinically based with approximately 200 outpt visits per month. Included in our clinical group are Stephen Duggan, Mary Ellen Morrissey, Kristen Rada, Cesar Vazquez and Steven Balk, Rupal Bhatt, and Marc Garnick. My interst is in newer targeted therapy for prostate cancer including targeting the PI3K/mTOR pathway for treatment of refractory prostate cancer. |
Publications
External Recognition
| DFCI SRC Director of GU ONC BIDMC National Co Chair of Inter Prostate Cancer Spore COmmittee for Clinical Research in Prostate Cancer Co PI of DF/HCC Prostate Cancer SPORE program |
Major Collaborative Activities
| DF/HCC |
Investigator's Lab Web Site
| Research Lab URL | None listed |
| Harvard Catalyst Site: | Bubley Harvard Catalyst Web Site |
